SCHEMBL1243460

SCHEMBL1243460

NC(Cc1ccccc1)(Cc1ccccc1)CP(=O)(O)O

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.50
HIF1A Q16665 1/20 0.50
ANPEP P15144 4/20 0.47
LAP3 P28838 3/20 0.47
SLC6A2 P23975 1/20 0.45
TAAR1 Q96RJ0 1/20 0.45
ERAP1 Q9NZ08 2/20 0.44
ERAP2 Q6P179 1/20 0.44
ACP3 P15309 2/20 0.42
TSHR P16473 1/20 0.41
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
GGPS1 O95749 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL1243123 0.95 SMN1; SMN2 (0.50) FDPSSMN1; SMN2HIF1AANPEPLAP3
SCHEMBL4093885 0.80 FDPS (0.62) FDPSSMN1; SMN2HIF1AANPEPLAP3
SCHEMBL3361671 0.78 FDPS (0.60) FDPSSMN1; SMN2HIF1AANPEPLAP3
SCHEMBL583541 0.76 TAAR1 (0.64) FDPSSMN1; SMN2HIF1ASLC6A2TAAR1
Hydrochloric Acid SCHEMBL5087218 0.74 TAAR1 (0.61) FDPSSMN1; SMN2HIF1ASLC6A2TAAR1
Water SCHEMBL8366271 0.74 TAAR1 (0.61) FDPSSMN1; SMN2HIF1ASLC6A2TAAR1
Bromide SCHEMBL5087806 0.74 TAAR1 (0.61) FDPSSMN1; SMN2HIF1ASLC6A2TAAR1
Iodide SCHEMBL5092148 0.74 TAAR1 (0.61) FDPSSMN1; SMN2HIF1ASLC6A2TAAR1
Phosphoric Acid SCHEMBL5459504 0.73 FDPS (0.58) FDPSSMN1; SMN2HIF1AANPEPLAP3
SCHEMBL4317428 0.73 FDPS (0.58) FDPSSMN1; SMN2HIF1ASLC6A2TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7879878-B2 such as {2-[({[7-(cyclohexylamino)-6-fluoro-4-oxo-1-[(3S)-tetrahydrofuran-3-yl]-1,4-dihydroquinolin-3-yl}carbonyl)amino]ethyl}phosphonic acid, used as platelet aggregation inhibitor and purinergic receptor (P2Y12) inhibitors; therapy for circulatory diseases involving thrombosis via platelet aggregation ASTELLAS PHARMA INC. (JP) 2011-02-01 US disclosed